Collegium Pharmaceutical Inc

+0.77 (+3.35%)
4:06:05 PM EDT: $23.77 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)809.78M
Current PEN/A
Forward PE 4.11
2yr Forward PE 3.12
See more stats
Estimates Current Quarter
Revenue$139.02 Million
Adjusted EPS$1.39
See more estimates
10-Day MA$24.15
50-Day MA$26.65
200-Day MA$20.95
See more pivots

Collegium Pharmaceutical Inc Stock, NASDAQ:COLL

100 Technology Center Drive, Suite 300, Stoughton, Massachusetts 02072
United States of America
Phone: +1.781.713.3699
Number of Employees: 207


Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.